Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Dementia
Clinical trial NCT04522739 · COMPLETED
Trial details
- NCT number
- NCT04522739
- Sponsor
- Emory University
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-06
- Primary completion
- 2025-09-23
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.